- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04656548
A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line
May 25, 2021 updated by: Access Vascular Inc
This is a retrospective, matched pair comparative post market review of 4Fr Single Lumen PICC lines.
The subjects will be matched by the timeframe of when the HydroPICCs were inserted.
Study Overview
Detailed Description
Subjects would have received a 4 Fr Single Lumen PICC line between Aug 2020 and Oct 2020.
The two groups will be HydroPICCs and the standard of care for the facility.
A comparison of multiple endpoints will be evaluated between the two groups.
Study Type
Observational
Enrollment (Actual)
121
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Romeoville, Illinois, United States, 60446
- Joseph Bunch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Any patients at the study site that received a 4 Fr single lumen PICC line from Aug 2020 through Oct 2020.
Description
Inclusion Criteria:
- Subjects who have been inserted with the HydroPICC during a specific time range.
- During the same time period, any competitor 4 Fr single lumen placed.
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
HydroPICC
Cohort who received the HydroPICC
|
PICC lines
Other Names:
|
Standard of Care
Cohort who received something different than HydroPICC
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intended dwell time based on a comparison of the actual dwell time to the intended time
Time Frame: August 2020 through October 2020
|
Comparison of actual vs intended dwell times of each arm
|
August 2020 through October 2020
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of failure rates
Time Frame: August 2020 through October 2020
|
Compare the failure rates between the two arms
|
August 2020 through October 2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joseph Bunch, ProVasc
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 13, 2020
Primary Completion (ACTUAL)
April 23, 2021
Study Completion (ACTUAL)
April 23, 2021
Study Registration Dates
First Submitted
December 1, 2020
First Submitted That Met QC Criteria
December 1, 2020
First Posted (ACTUAL)
December 7, 2020
Study Record Updates
Last Update Posted (ACTUAL)
May 26, 2021
Last Update Submitted That Met QC Criteria
May 25, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- CLIN 20-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PICC
-
C. R. BardKJT Group, Inc.CompletedIndication for PICC PlacementUnited States
-
Second Affiliated Hospital, School of Medicine,...Sir Run Run Shaw Hospital; Zhejiang Provincial People's HospitalActive, not recruitingCancer Patients With PICCChina
-
Equipo de Terapia IntravenosaHospital San Carlos, MadridCompleted
-
Shandong Branden Med.Device Co.,LtdWuhan University; Hubei Cancer Hospital; Yichang Central People's Hospital; Wuhan... and other collaboratorsNot yet recruitingthe Incidence of PICC-related Complications
-
VasoNova, Inc.CompletedAny Condition Requiring a PICC PlacementUnited States
-
Jena University HospitalCompleted
-
C. R. BardTerminatedPrimary Focus: Adult Subjects Who Require PICC PlacementUnited States
-
Milton S. Hershey Medical CenterCompletedCentral Venous Catheter | Central Line | PICC | Neuro ICU | Neuroscience ICU | CVCUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompletedPatients With Any Condition Who Need a PICC for IV TherapyBelgium
-
National Cancer Center, KoreaCompletedPatients Cannulated With Both PICC and CICC. | The Rapidly Fluctuating Hemodynamics During LT.Korea, Republic of
Clinical Trials on HydroPICC
-
Access Vascular IncTerminated